Clinical trial
Two-Drug Combination Chemotherapy Compared With Four-Drug Combination…
NCT00003376 · Eastern Cooperative Oncology Group, Other · Completed
Key facts
| NCT number | NCT00003376 |
|---|---|
| Title | Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium |
| Official title | Phase III Trial of Methotrexate, Vinblastine, Doxorubicin and Cisplatin vs Carboplatin and Paclitaxel in Advanced Carcinoma of the Urothelium |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH Cancer and Leukemia Group B |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, cisplatin, doxorubicin hydrochloride, methotrexate, paclitaxel, vinblastine |
| Enrollment | 330 |
| Start date | Dec 3, 1998 |
| Primary completion | Sep 1, 2005 |
| First posted | Apr 9, 2004 |
| Last update posted | Jun 22, 2023 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: